Advances in technology have made it possible for surgeons to insert vessels within the body of only 0.3 mm in diameter . The success of the procedure, however, depends crucially on the accuracy and stability of the doctor's hands.
Ultrasound surgery with the help of a robotic platform can solve this problem as it allows for finer and steady movements to be performed . MicroSure's new MUSA robot was tested for the first time in 20 patients with breast cancer and lymphedema , who were randomly divided into two groups and underwent surgery either by human surgeons or with the help of the robotic system.
The robotic system helped doctors move the breast lymph vessels and reconnect them to blood vessels .
The scientists evaluated the operation in terms of duration ( 16 to 20 minutes ) and success, as well as the condition of the patients both one month and three months after the operation. It has been found that the use of robotic hypermicrosurgery in humans is indeed feasible and has led to improved quality of life for patients.
The doctors, led by Tom Van Mulken of the Maastricht University Medical Center, who published the study in Nature Communications, said that larger clinical trials in more patients and involving more surgeons would require more surgeons. the first positive results, which are very promising for the future of robotic supermicrosurgery.